Recent Advances in Bariatric Surgery

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Methodology, Drug and Device Discovery".

Deadline for manuscript submissions: 25 November 2025 | Viewed by 1319

Special Issue Editors


E-Mail Website
Guest Editor
Department of General Surgery, Cannizzaro Hospital, via Messina 829, 95126 Catania, Italy
Interests: gastrointestinal surgery; surgical oncology; bariatric surgery; post-bariatric surgery; gut microbiome; emergency ultrasound

E-Mail Website
Guest Editor
Department of Surgery, Fondazione IRCCS Policlinico San Matteo, viale Camillo Golgi 19, 27100 Pavia, Italy
Interests: bariatric surgery; vascular surgery; transplant surgery; laparoscopic surgery; robotic surgery

Special Issue Information

Dear Colleagues,

Obesity is currently considered a global epidemic condition, and bariatric/metabolic surgery has emerged as an option for achieving significant and durable weight loss in the treatment of clinically severe obesity.

There is increasing demand for bariatric/metabolic surgery worldwide; in fact, thousands of bariatric procedures are currently being performed around the world with exponentially increasing trends and outcomes.

Over the years, much research has been performed in this field, generating a high degree of knowledge on the effect of bariatric procedures on obesity comorbidities and its effectiveness over the time. In addition, new procedures have been developed and have changed the face of modern bariatric surgery.

The aim of this Special Issue is to provide an overview of recent advances in the field of bariatric surgery. Therefore, we encourage researchers in the field of bariatric surgery to submit an original article (no animal research) or review to this Special Issue (case reports and short reviews will not be accepted).

Dr. Maria Sofia
Prof. Dr. Andrea Peri
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bariatric surgery
  • morbid obesity
  • sleeve gastrectomy
  • gastric bypass
  • emerging procedures
  • early outcomes
  • long-term results

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 2031 KiB  
Article
Postoperative Biochemical Outcomes in Metabolic Bariatric Surgery: Results from a High-Adherence Cohort
by Maria Sofia, Marcello Agosta, Sara D’Amato, Giuseppe Nicolò Conti, Chiara Mazzone, Gloria Faletra, Gaetano La Greca and Saverio Latteri
J. Pers. Med. 2025, 15(1), 7; https://doi.org/10.3390/jpm15010007 - 27 Dec 2024
Cited by 1 | Viewed by 769
Abstract
Background/Objectives: In metabolic bariatric surgery, structured follow-up protocols may play an essential role in achieving optimal patient outcomes. This study aims to report postoperative biochemical outcomes in a cohort of post-bariatric patients who underwent a structured follow-up protocol. Methods: This retrospective study included [...] Read more.
Background/Objectives: In metabolic bariatric surgery, structured follow-up protocols may play an essential role in achieving optimal patient outcomes. This study aims to report postoperative biochemical outcomes in a cohort of post-bariatric patients who underwent a structured follow-up protocol. Methods: This retrospective study included patients who underwent metabolic bariatric surgery and completed a one-year follow-up at Cannizaro Hospital from October 2022 to May 2024. Anthropometric, clinical, and laboratory data were collected for each patient at five different timepoints: baseline, 1, 3, 6, and 12 months post-surgery. All data were organized into a database and analyzed through descriptive statistics. Results: The study cohort (n = 80) showed a follow-up adherence equal to 97.5%. The mean value of BMI decreased from 42 to 27 one year after surgery. Lipid profiles improved, with significant reduction in total cholesterol and triglycerides and increase in HDL levels; LDL levels decreased initially but at one year returned to baseline. Thyroid hormones TSH and fT3 decreased significantly, while fT4 remained stable. A reduction in hepatic inflammation was observed, as evidenced by the decrease in GGT and transaminase levels. Pancreatic enzymes showed an initial increase but stabilized at the subsequent timepoints. Glycemic control improved, with statistically significant reductions in insulin, HbA1c, and glucose levels, and complete remission of type 2 diabetes mellitus in affected patients. Conclusions: This study shows significant weight loss and improved health outcomes in post-bariatric patients who underwent a structured follow-up protocol, suggesting the potential benefits of metabolic bariatric surgery. Full article
(This article belongs to the Special Issue Recent Advances in Bariatric Surgery)
Show Figures

Figure 1

Back to TopTop